glp-1 news october 1 2025 dominates for trial activity How FDA Crackdowns Are Affecting – GLP-1 RA prescription trends: January

Dysbiosis in the gut, particularly reduced microbial diversity, correlates with increased eczema severity in both children and adults

Medical oversight: Warning signs to watch for: The FDA has also updated warnings for medications like Ozempic to include the risk of ileus (a blockage in the intestines)

Some peptides and amino acids trigger the release of GLP-1 in the intestines

No universal injection volume applies to every patient

Nevertheless, astrocytes and other glia can also mediate detrimental effects in neurological disorders either through downregulation of essential functions or through gain of inappropriate functions such as promoting excess inflammation

With long term use (couple of months) can see the result